ArticleJournal of the advanced practitioner in oncology2024
Advances in Myelofibrosis Management: New Janus Kinase Inhibitors Beyond Ruxolitinib.
Justin Arnall et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it